Skip to content
2000
Volume 23, Issue 21
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Pompe disease or glycogen storage disease type II (OMIM: 232300) is a lysosomal storage disorder resulting from a partial or total lack of acid alphaglucosidase, which may produce muscle weakness, gait abnormalities, or even death by respiratory failure. In the last decade, autophagy has been proposed as a mechanism involved in the severity of symptoms related to this disorder and as a potential therapeutic target to alleviate disease progression. This review summarizes the relationship between autophagy and Pompe disease, including what information has been recently discovered and what remains unclear.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/1567201812666150122131046
2016-06-01
2025-04-19
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/1567201812666150122131046
Loading

  • Article Type:
    Research Article
Keyword(s): Autophagy; Glycogen synthase; LC3; Lysosomes; Pompe disease; Recombinant human GAA
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test